Healthcare -
Biotechnology - NYSE - US
$ 4.9993
2.24 %
$ 69 M
Market Cap
-1.18
P/E
ANVS - CHANGE IN WORKING CAPITAL
Change in Working Capital ANVS - Annovis Bio, Inc.
2.44 M
LAST VALUE
92.66%
2 YEAR CAGR
102.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR